Search results for "Coronavirus"


 
Results 51 - 60 of about 166 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19

During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
https://acpinternist.org/weekly/archives/2022/02/01/2.htm
1 Feb 2022

We must rise with the occasion and save our country

The current COVID-19 pandemic requires that ACP carefully craft public policies not only for how care is organized and delivered on the front lines but also for helping physicians save patients while keeping themselves safe as well.
https://acpinternist.org/archives/2020/05/we-must-rise-with-the-occasion-and-save-our-country.htm
1 May 2020

New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions

A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://acpinternist.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022

New research on PASC, COVID-19 infection and vaccination during pregnancy

Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://acpinternist.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022

COVID-19 vaccine protection, primary care delays and international differences during the pandemic

An analysis of the omicron surge found that unvaccinated people were 23 times more likely to be hospitalized than those who got a booster. Two studies assessed how the pandemic delayed primary care, and an international study tied lower infection rates to trust in government.
https://acpinternist.org/weekly/archives/2022/02/08/1.htm
8 Feb 2022

And the winner is …

ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.
https://acpinternist.org/weekly/archives/2022/01/25/7.htm
25 Jan 2022

Vote for your favorite entry

ACP Internist Weekly's cartoon caption contest continues. Readers can vote for their favorite caption to determine the winner.
https://acpinternist.org/weekly/archives/2022/01/18/7.htm
18 Jan 2022

New research on mixed vaccine boosters, long-term outcomes, omicron severity

A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://acpinternist.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022

New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis

The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://acpinternist.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022

Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk

Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://acpinternist.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next